Pages that link to "Q37461901"

The following pages link to MicroRNA involvement in the pathogenesis and management of breast cancer. (Q37461901):

Displaying 37 items.

• Identification of differentially expressed microRNAs in human male breast cancer (Q21261330) (← links)
• Significance of PELP1/HDAC2/miR-200 regulatory network in EMT and metastasis of breast cancer (Q28297295) (← links)
• Integrating sequence, expression and interaction data to determine condition-specific miRNA regulation (Q30652398) (← links)
• MicroRNA Profiling Using Fluorescence-Labeled Beads: Data Acquisition and Processing (Q33712931) (← links)
• Large-scale investigation of human TF-miRNA relations based on coexpression profiles (Q33796846) (← links)
• MicroRNA profiles of healthy basal and luminal mammary epithelial cells are distinct and reflected in different breast cancer subtypes. (Q33847989) (← links)
• microRNA Expression Profiling in Archival Tissue Specimens: Methods and Data Processing (Q33938274) (← links)
• Induction of cellular senescence by doxorubicin is associated with upregulated miR-375 and induction of autophagy in K562 cells (Q34273930) (← links)
• Direct quantification of mRNA and miRNA from cell lysates using reverse transcription real time PCR: a multidimensional analysis of the performance of reagents and workflows (Q34988433) (← links)
• Functional analysis of microRNA and transcription factor synergistic regulatory network based on identifying regulatory motifs in non-small cell lung cancer (Q35033480) (← links)
• MiR-217 Promotes Tumor Proliferation in Breast Cancer via Targeting DACH1 (Q35040929) (← links)
• The emerging role of microRNAs in drug responses (Q35599477) (← links)
• RETRACTED ARTICLE: Down-regulated microRNA-124 expression as predictive biomarker and its prognostic significance with clinicopathological features in breast cancer patients (Q36105115) (← links)
• MicroRNA-205 increases the sensitivity of docetaxel in breast cancer (Q36523888) (← links)
• Regulation of miR106b cluster through the RB pathway: mechanism and functional targets (Q36604665) (← links)
• Radiation-induced micro-RNA expression changes in peripheral blood cells of radiotherapy patients (Q36661037) (← links)
• MicroRNA-210 interacts with FBXO31 to regulate cancer proliferation cell cycle and migration in human breast cancer (Q37213238) (← links)
• MicroRNA expression profiling of male breast cancer (Q37360228) (← links)
• Micro-RNAs and breast cancer (Q37764166) (← links)
• Personalized Medicine: The Road Ahead (Q37855305) (← links)
• Implication of miRNA in the diagnosis and treatment of breast cancer. (Q37931898) (← links)
• Regulation of Aerobic Glycolysis by microRNAs in Cancer (Q38026041) (← links)
• MicroRNAs and cancer stem cells: the sword and the shield (Q38163328) (← links)
• Epigenetically regulated microRNAs and their prospect in cancer diagnosis (Q38219046) (← links)
• Regulation of epithelial-mesenchymal transition through microRNAs: clinical and biological significance of microRNAs in breast cancer. (Q38958559) (← links)
• MicroRNA expression profiling identifies decreased expression of miR-205 in inflammatory breast cancer. (Q40887298) (← links)
• The microRNA maturation regulator Drosha is an independent predictor of outcome in breast cancer patients (Q45350621) (← links)
• Triple-negative and luminal A breast tumors: differential expression of miR-18a-5p, miR-17-5p, and miR-20a-5p (Q46680147) (← links)
• MicroRNA-588 is downregulated and may have prognostic and functional roles in human breast cancer. (Q47137394) (← links)
• HDAC inhibitor suppresses proliferation and invasion of breast cancer cells through regulation of miR-200c targeting CRKL. (Q47385628) (← links)
• Profiling differential microRNA expression between in situ, infiltrative and lympho-vascular space invasive breast cancer: a pilot study (Q48163436) (← links)
• HER2 positivity may confer resistance to therapy with paclitaxel in breast cancer cell lines (Q50643855) (← links)
• MicroRNA-409-5p is upregulated in breast cancer and its downregulation inhibits cancer development through downstream target of RSU1. (Q50687509) (← links)
• Genetic variants within miR-126 and miR-335 are not associated with breast cancer risk. (Q53291654) (← links)
• Circulating miRNA is a novel marker for head and neck squamous cell carcinoma. (Q54300178) (← links)
• MicroRNA Microarray Profiling in Infantile Hemangiomas (Q64107857) (← links)
• MiR-33a functions as a tumor suppressor in triple-negative breast cancer by targeting EZH2 (Q90608122) (← links)